Pharmerging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 According to a new study by Transparency Market Research (TMR), the global pharmerging market is highly competitive in nature. Led by Johnson & Johnson, F. Hoffmann-La Roche Ltd., Novartis AG, and Merck & Co. Inc., the market demonstrates an extremely fragmented structure. The leading players are focusing on product innovation to strengthen their market presence, which, consequently, is increasing research and development activities in the market. Over the coming years, the involvement of these players will increase in mergers and acquisitions directed towards the expansion of their businesses, states the research report. As per TMR’s estimations, the global market for pharmerging stood at US$552.8 mn in 2015. Researchers expect it to rise at a CAGR of 11.30% during the period from 2016 to 2024 and reach a value of US$1.40 bn by the end of the forecast period. The market has been witnessing a higher demand for pharmaceuticals products and the trend is expected to continue over the next few years, thanks to the growing requirement of branded as well as generic drugs.
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.